217 related articles for article (PubMed ID: 34260813)
1. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19.
Li A; Kuderer NM; Hsu CY; Shyr Y; Warner JL; Shah DP; Kumar V; Shah S; Kulkarni AA; Fu J; Gulati S; Zon RL; Li M; Desai A; Egan PC; Bakouny Z; Kc D; Hwang C; Akpan IJ; McKay RR; Girard J; Schmidt AL; Halmos B; Thompson MA; Patel JM; Pennell NA; Peters S; Elshoury A; de Lima Lopes G; Stover DG; Grivas P; Rini BI; Painter CA; Mishra S; Connors JM; Lyman GH; Rosovsky RP;
J Thromb Haemost; 2021 Oct; 19(10):2522-2532. PubMed ID: 34260813
[TBL] [Abstract][Full Text] [Related]
2. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
[TBL] [Abstract][Full Text] [Related]
3. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Gulati S; Hsu CY; Shah S; Shah PK; Zon R; Alsamarai S; Awosika J; El-Bakouny Z; Bashir B; Beeghly A; Berg S; de-la-Rosa-Martinez D; Doroshow DB; Egan PC; Fein J; Flora DB; Friese CR; Fromowitz A; Griffiths EA; Hwang C; Jani C; Joshi M; Khan H; Klein EJ; Heater NK; Koshkin VS; Kwon DH; Labaki C; Latif T; McKay RR; Nagaraj G; Nakasone ES; Nonato T; Polimera HV; Puc M; Razavi P; Ruiz-Garcia E; Saliby RM; Shastri A; Singh SRK; Tagalakis V; Vilar-Compte D; Weissmann LB; Wilkins CR; Wise-Draper TM; Wotman MT; Yoon JJ; Mishra S; Grivas P; Shyr Y; Warner JL; Connors JM; Shah DP; Rosovsky RP;
JAMA Oncol; 2023 Oct; 9(10):1390-1400. PubMed ID: 37589970
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer.
Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C
J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
[TBL] [Abstract][Full Text] [Related]
6. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid.
Paredes-Ruiz D; Gómez-Cuervo C; Gómez-Martín C; Sánchez-Guerrero Á; González-Olmedo J; López-López F; Bover-Larroya M; Yarza-Barrio R; Jara-Casas DD; Castelo-Laureiro A; Revilla-Ostolaza Y; Paz-Ares L; Lumbreras-Bermejo C; Díaz-Pedroche C
J Thromb Thrombolysis; 2022 Feb; 53(2):471-478. PubMed ID: 33890200
[TBL] [Abstract][Full Text] [Related]
7. Venous Thromboembolism in Patients Hospitalized for COVID-19 in a Non-Intensive Care Unit.
Mackiewicz-Milewska M; Cisowska-Adamiak M; Pyskir J; Świątkiewicz I
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256663
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory and Hemostatic Markers in COVID-19 Patients with Arterial Thrombosis Are Significantly Lower at Hospital Admission than in COVID-19 Patients without Thrombosis.
de Oliveira M; Cubal F; Coutinho M; Pereira M; Cruz E; Morais S
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366428
[TBL] [Abstract][Full Text] [Related]
9. Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
Arribalzaga K; Martínez-Alfonzo I; Díaz-Aizpún C; Gutiérrez-Jomarrón I; Rodríguez M; Castro Quismondo N; Pérez-Fernández E; Velasco-Rodríguez D; Gómez E; Fernández B; Vilches A; Martín-Herrero S; Castilla L; Blanco MJ; Gutiérrez MDM; Rivas I; Pascual C; Rosado B; Sola E; Vidal-Laso R; Asenjo S; Mora Casado MA; Benito-Parra L; Carmona I; Marín K; Acedo N; García-León N; Marcheco A; Guillén C; Fernández C; Rodríguez R; Pardo L; Silva P; Montero L; Meijón M; Massó P; Llamas-Sillero P;
Thromb Res; 2021 Jul; 203():93-100. PubMed ID: 33989984
[TBL] [Abstract][Full Text] [Related]
10. External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19.
Goldin M; Lin SK; Kohn N; Qiu M; Cohen SL; Barish MA; Gianos E; Diaz A; Richardson S; Giannis D; Chatterjee S; Coppa K; Hirsch JS; Ngu S; Firoozan S; McGinn T; Spyropoulos AC
J Thromb Thrombolysis; 2021 Nov; 52(4):1032-1035. PubMed ID: 34146235
[TBL] [Abstract][Full Text] [Related]
11. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I;
Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032
[TBL] [Abstract][Full Text] [Related]
12. Incidence of venous thromboembolism in hospitalized patients with COVID-19.
Middeldorp S; Coppens M; van Haaps TF; Foppen M; Vlaar AP; Müller MCA; Bouman CCS; Beenen LFM; Kootte RS; Heijmans J; Smits LP; Bonta PI; van Es N
J Thromb Haemost; 2020 Aug; 18(8):1995-2002. PubMed ID: 32369666
[TBL] [Abstract][Full Text] [Related]
13. External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort.
Blondon M; Righini M; Nendaz M; Glauser F; Robert-Ebadi H; Prandoni P; Barbar S
J Thromb Haemost; 2020 Mar; 18(3):676-680. PubMed ID: 31782886
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.
Wang L; Zhao L; Li F; Liu J; Zhang L; Li Q; Gu J; Liang S; Zhao Q; Liu J; Xu JF
Clin Respir J; 2022 Mar; 16(3):182-189. PubMed ID: 35060325
[TBL] [Abstract][Full Text] [Related]
15. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
[TBL] [Abstract][Full Text] [Related]
17. The ICU-venous thromboembolism score and tumor grade can predict inhospital venous thromboembolism occurrence in critical patients with tumors.
Mei R; Wang G; Chen R; Wang H
World J Surg Oncol; 2022 Sep; 20(1):245. PubMed ID: 36058927
[TBL] [Abstract][Full Text] [Related]
18. Predictors of venous thromboembolism in patients with COVID-19 in an underserved urban population: A single tertiary center experience.
Barnes DH; Lo KB; Bhargav R; Gul F; DeJoy R; Peterson E; Salacup G; Pelayo J; Albano J; Azmaiparashvili Z; Rangaswami J; Carpio AM; Patarroyo-Aponte G
Clin Respir J; 2021 Aug; 15(8):885-891. PubMed ID: 33864721
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study.
Lee Y; Jehangir Q; Li P; Gudimella D; Mahale P; Lin CH; Apala DR; Krishnamoorthy G; Halabi AR; Patel K; Poisson L; Balijepally V; Sule AA; Nair GB
BMC Infect Dis; 2022 May; 22(1):462. PubMed ID: 35562677
[TBL] [Abstract][Full Text] [Related]
20. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
